The United States represents the largest share of the Indomethacin Market, driven by the high prevalence of arthritis, gout, and chronic inflammatory disorders. Strong healthcare infrastructure, extensive access to prescription medications, and growing demand for effective pain management therapies continue to support market growth. Additionally, the country's aging population and increasing...